Ann Rheum Dis. 2019;78(9):1283-1284.
Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.
제1저자 박진균 · 교신저자 이은봉
소속 (4)
- Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University College of medicine, Seoul, Republic of Korea.
- Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA.
- Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea leb7616@snu.ac.kr.
Keywords
discontinuationinfluenzamethotrexaterheumatoid arthritisvaccination
Conflict of interest statement
Competing interests: EBL has acted as a consultant to Pfizer and has received research grants from GC Pharma and Hanmi Pharm.
그 밖의 정보
- 출판 형태
- Letter, Research Support, Non-U.S. Gov't
- 저널
- Annals of the rheumatic diseases · eISSN 1468-2060
- 전자 출판
- 2019-03-23
- MeSH
- Antirheumatic Agents / administration & dosage · Arthritis, Rheumatoid / complications / drug therapy · Humans · Influenza A virus / immunology · Influenza Vaccines / pharmacology · Influenza, Human / complications / prevention & control · Methotrexate / administration & dosage · Randomized Controlled Trials as Topic · Seasons · Vaccination / methods
- Substances
- Antirheumatic Agents · Influenza Vaccines · Methotrexate
- 데이터
- ClinicalTrials.gov: NCT02897011